Inventor · disambiguated record
Vineet Pande
Also filed as: PANDE VINEET
20 granted patents·11 pending applications·31 citations·filing 2016–2023
91Inventor score
Files withJANSSEN PHARMACEUTICA NV31
Top patents by PatentIndex Score
31 records- 0192US11702441B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 18, 2023·2 cites·2 claims
- 0292US11059850B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 13, 2021·8 cites·21 claims
- 0391US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0484US12145961B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Nov 19, 2024·0 cites·1 claims
- 0584US10611778B2Fused bicyclic inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 7, 2020·3 cites·10 claims
- 0683US11530226B2Azepane inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·1 cites·8 claims
- 0783US11396517B1Exo-aza spiro inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 26, 2022·6 cites·13 claims
- 0883US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0980US10975100B2Fused bicyclic inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 13, 2021·1 cites·6 claims
- 1077US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1177US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1275US10745409B2Azepane inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 18, 2020·1 cites·10 claims
- 1374US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1473US10501469B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 10, 2019·1 cites·53 claims
- 1570US11220517B2Spiro bicyclic inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 11, 2022·1 cites·12 claims
- 1668US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 1767US10981926B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 20, 2021·0 cites·51 claims
- 1860US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 1960US2019337924A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2059US2019330190A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2158US2025197392A1Crystalline forms of an inhibitor of the menin/mll interactionJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2257US2023039917A1Exo-aza spiro inhibitors of menin-mll interactionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2355US12084462B2Spiro bicyclic inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 10, 2024·0 cites·14 claims
- 2455US2025302840A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2555US2025333421A1Pyridazines or 1,2,4-triazines substituted by spirocyclic aminesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2655US2023250096A1SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVESJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2755US2024417405A1Substituted Spiro DerivativesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2854US12473295B2Substituted straight chain spiro derivativesJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 18, 2025·0 cites·20 claims
- 2953US2024261292A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3049US10000502B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 19, 2018·0 cites·25 claims
- 3144US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Vineet Pande files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →